Visitors and news

Dr Isabel Mosquera, PhD in Public Health at the University of the Basque Country (UPV/EHU), has recently joined the Screening Group at IARC as a postdoctoral fellow.Isabel will be involved in the review of interventions to reduce health inequalities in cervical cancer screening.

Dr Xuelian Zhao, PhD in Peking Union Medical College (PUMC), from National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (NCC/CHCAMS), joined the Screening Group for 6 months and will be involved mainly in the analysis of cervical cancer screening and management data in China in collaboration with Dr Fanguhi Zhao.

Dr Partha Basu participated in this expert advisory group meeting on cervical cancer elimination initiative organized by the WHO. Visit the WHO Cervical cancer elimination strategy page.

The Screening Group (SCR) team is saddened by the passing of long-time SCR collaborator Doctor Srabani Mittal from Kolkata, India, who died on Saturday 10 August 2019 in Dhaka, Bangladesh.
Read the IARC news.

Registration of new trainers and trainees for the IFCPC-IARC Training course in Colposcopy and the prevention of Cervical Cancer will be open at the IFCPC-IARC stall at the 33rd Annual Conference of AICC RCOG 2019.
Exciting new opportunities for the trainers and trainees.
For further details about this training and registration.

As part of the 33rd Annual Conference of AICC RCOG 2019, a post-congress workshop will be organized by IARC and IFCPC. Faculty include Dr. R. Sankaranarayanan, Dr Partha Basu, Dr. Neerja Bhatla and Dr. Theresa Freeman Wong.
More details available here for the registration.

This new article, published in the 6^th edition of the annual Cancer Control 2019, presented the new IARC initiative, CanScreen5 platform to uniformly collect, analyse, store and disseminate information on characteristics and performance of cancer screening pogrammes. This new initiative will impress upon the programme managers the value of monitoring and quality improvement of cancer screening programmes and also support capacity-building in this area.View the article and visit the CanScreen5 platform.

The Screening Group is delighted to present the findings of this study which aimed to determine the clinical performance of HPV mRNA compared with HPV DNA testing in North Eastern Thailand in the setting of the cervical cancer screening national program. The test characteristics of HPV DNA test and HPV mRNA test for primary screening were comparable. View the article.

Dr Catherine Sauvaget participated to a cancer control assessment mission organised by IAEA, WHO and IARC in the Seychelles.

Dr Partha Basu attended the Mission organized by the WHO (EMRO) in collaboration with the Ministry of Health, Palestine to improve cancer care including breast cancer early detection in Palestine.